This is an observational study that will test the clinical significance of speech features in patients with cirrhosis. It aims to assess if speech is associated with cognitive function at baseline, if speech predicts changes in cognition, and if speech predicts future events of hepatic encephalopathy (cirrhosis-related confusion), as well as to assess the dynamics of speech over time, especially with episodes of overt hepatic encephalopathy (OHE) and treatment interventions.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Psychometric Hepatic Encephalopathy Score (PHES) from Baseline to 6 Months
Timeframe: 6 Months
Change in Psychometric Hepatic Encephalopathy Score (PHES) from Baseline to 12 Months
Timeframe: 12 Months
Speech Assessments
Timeframe: 12 Months
Time to Overt Hepatic Encephalopathy (HE)
Timeframe: 12 Months